Key facts
- It has raised $56.8M; the latest was Later Stage VC ($34.0M) in May 2025.
- Notable investors include US National Science Foundation, National Institutes of Health, Gates Foundation, Hong Kong Science & Technology Parks, Joseph Tam — 9 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 9 names
- ·Watchlist + deal alerts for Phase Scientific
- ·The full record, as it builds
Funding rounds
No funding rounds for Phase Scientific are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Phase Scientific
Developer of point-of-care diagnostic kits designed for major unmet testing needs. The company's kits aim to replace lab-based assays for Chlamydia trachomatis CT and expand testing accessibility to previously unreachable settings, which are being provided by applying a paper microfluidic concentration platform, enabling the diagnostics and healthcare management sector to purchase their kit for sexually transmitted diseases and a rapid saliva-based malaria test.
- Sector
- Healthcare
- HQ
- Hong Kong, Hong Kong
- Founded
- 2014
- Employees
- 20
- Website
- phasescientific.com/
- Ownership
- Privately Held (backing)
Phase Scientific doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Phase Scientific shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Phase Scientific in its N-PORT filings yet. We sweep new filings monthly.